Private Companies
Cannabis Science Conference to debut in Providence, R.I., with renewed focus on analytical science, medical cannabis, cultivation and psychedelics
2023 Providence show will feature expert-led cannabis science education and insights, presentations and networking opportunities
Cannabis Science Conference…
2023 Providence show will feature expert-led cannabis science education and insights, presentations and networking opportunities
Cannabis Science Conference to debut in Providence, R.I., from September 20–22
PROVIDENCE, R.I., July 18, 2023 (GLOBE NEWSWIRE) -- Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation and psychedelics, announced today that its fall edition will make its first-ever appearance in Providence, R.I. Taking place at the Rhode Island Convention Center from September 20–22, this highly anticipated conference will become the epicenter for education related to the exciting cannabis and psychedelic markets.
“We are thrilled to bring the Cannabis Science Conference to Providence,” said Megan L’Heureux, group editorial director of Cannabis Science and Technology® and Cannabis Patient Care™ magazines. “Rhode Island is emerging as a major player in the cannabis science industry, and this event will serve as a dynamic hub for professionals to learn, network and collaborate.”
Keynote speaker Dr. Peter Grinspoon, a primary care doctor at Massachusetts General Hospital, instructor in medicine at Harvard Medical School, and 25-year cannabis specialist, will share his knowledge in an address titled, “Cannabis Reconsidered: A Science-Based Look at the True Harms and Benefits.” In a recent interview with Cannabis Science and Technology, Grinspoon discussed what he hoped attendees will learn from this presentation. “We all need to be humble. We all need to forget what we think we know about cannabis. Nobody, including me, has a monopoly on the truth. We just have to think for ourselves,” said Dr. Grinspoon. “I'm just really hoping that by challenging some of the myths, methodology, and misconceptions that people will come away feeling more confident in thinking for themselves on this issue.”
Dr. Dustin Sulak, a distinguished integrative medicine physician, will also take the stage at the fall event for a keynote address. With a deep-rooted practice in osteopathy, mind-body medicine and medical cannabis applications, Dr. Sulak is renowned for his expertise in the medical use of cannabis. His keynote address, “The Knowledge and Art of Combining Cannabinoids for Treatment Success,” will explore recent advancements in accessing rare cannabinoids and challenge assumptions about THC and CBD combinations. CSC will also feature several fireside chats with industry experts such as world-renowned cannabis geneticist Adam Jacques as well as a hot button discussion on THC potency inflation with leading analytical scientists.
CSC is designed to provide world-class science education and insights. Attendees can expect expert-led presentations, roundtable discussions, exhibits and a full-day pre-conference workshop called Canna Boot Camp, taking place on September 20. Canna Boot Camp covers a wide range of cannabis science topics, including cultivation, preprocessing, sample preparation, analytical testing, extraction and edibles manufacturing.
The conference boasts dedicated program chairs and an educational steering committee, ensuring the highest quality and relevant content. CSC places great emphasis on networking and collaboration opportunities among attendees, speakers and exhibitors, fostering a vibrant atmosphere for knowledge exchange and business growth within the cannabis industry.
To register and learn more, please visit the registration page.
About Cannabis Science Conference:
Cannabis Science Conference (CSC) is the industry’s premier science event, focusing on analytical science, medical cannabis, cultivation and psychedelics. CSC brings together cannabis and psychedelic industry experts, including instrument manufacturers, testing labs, research scientists, cultivators, medical practitioners, policy makers, patients and interested novices to network and share ideas. CSC runs semiannual events nationwide in emerging markets, aimed at improving cannabis and psychedelic science. Join us for world-class education, stellar networking and the opportunity to connect with thought leaders, leading scientists, pioneers in cutting-edge medical applications and industry suppliers. For more information, visit www.cannabisscienceconference.com.
Media Contact:
Lauren Garafola
MJH Life Sciences®
lgarafola@mjhlifesciences.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0392bfc7-563b-4b86-bd0d-9e70982b71a3
psychedelics psychedelic psychedelic science
-
Psilocybin1 week ago
California advances bill for psychedelics centers
-
Psilocybin6 days ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
Psychedelics Can Offer More Than Therapy On Its Own
-
Psychedelics5 days ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics6 days ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Law & Regulation5 days ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psychedelics5 days ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics6 days ago
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research